Editas Medicine
The Senior QA Specialist is responsible for ensuring the quality and reliability of biotechnology products through rigorous testing and analysis. This role involves developing test plans, executing test cases, and collaborating with cross‑functional teams to identify and resolve issues, supporting the company's commitment to high standards and regulatory compliance.
Headquarters
Cambridge, Massachusetts, United States
Company Size
201-500 employees
Founded
2013
Editas Medicine is a leading biotechnology company focused on developing CRISPR-based medicines to treat people with serious diseases. It pioneers genome-editing therapies, translating CRISPR research into clinical programs aimed at delivering transformative treatments. The company concentrates on building a pipeline of investigational medicines and collaborating across the biotech ecosystem to advance gene editing from the lab to the clinic. By leveraging precision genome editing, Editas Medicine seeks to expand treatment options for patients with previously intractable conditions.
Gene edit slashes cholesterol 90% in tests; human trial next for Editas
4 days ago
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
4 days ago
Editas Medicine (EDIT) Q3 Loss Improvement Tests Bearish Earnings Decline Narrative
3 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Editas Medicine.
Editas Medicine didn’t post a salary, so this is our estimate from similar listings.
10% below the average for this role
Editas Medicine (EDIT) Reports Fourth Quarter Financials and Advances Gene Editing Strategy
4 days ago